Works by de Jong, Igle J.

Results: 32

Optimization of Cone Beam Computed Tomography Scan Protocols for the Intraoperative Detection of Residual Stones in Percutaneous Nephrolithotomy.

Published in:

Journal of Endourology, 2025, v. 39, n. 5, p. 509, doi. 10.1089/end.2024.0732

By:

Kingma, Riemer Adam;
van Asten, Nienke T.L.;
Greuter, Marcel J.W.;
de Jong, Igle J.;
Roemeling, Stijn

Publication type:

Article

Tc-HDP bone scintigraphy and F-sodiumfluoride PET/CT in primary staging of patients with prostate cancer.

Published in:

World Journal of Urology, 2018, v. 36, n. 1, p. 27, doi. 10.1007/s00345-017-2096-3

By:

Wondergem, Maurits;
van der Zant, Friso M.;
Knol, Remco J. J.;
Burgers, Anne Marij G.;
Bos, Siebe D.;
de Jong, Igle J.;
Pruim, Jan

Publication type:

Article

Treatment and outcome in muscle invasive bladder cancer: a population-based survey.

Published in:

World Journal of Urology, 2010, v. 28, n. 4, p. 439, doi. 10.1007/s00345-010-0546-2

By:

Leliveld, Anna M.;
Doornweerd, Benjamin H. J.;
Bastiaannet, Esther;
Schaapveld, Michael;
de Jong, Igle J.

Publication type:

Article

Cognitive Impairment in Long-Term Survivors of Testicular Cancer More Than 20 Years after Treatment.

Published in:

Cancers, 2021, v. 13, n. 22, p. 5675, doi. 10.3390/cancers13225675

By:

Stelwagen, Johannes;
Meuleman, Andrea T.;
Lubberts, Sjoukje;
Steursma, Gerrie;
Kruyt, Lara M.;
Donkerbroek, Jan W.;
Meijer, Coby;
Walenkamp, Annemiek M. E.;
Lefrandt, Joop D.;
Rakers, Sandra E.;
Huitema, Rients B.;
de Jong, Marianne A. A.;
Wiegman, Erwin M.;
van den Bergh, Alfons C. M.;
de Jong, Igle J.;
van Rentergem, Joost A. Agelink;
Schagen, Sanne B.;
Nuver, Janine;
Gietema, Jourik A.

Publication type:

Article

Response to: Fu-Xiang Lin, Yi Yu, Zhan-Ping Xu Letter to Editor: Unveiling the Crystal Clear: Cone Beam Computed Tomography's Role in Enhancing PCNL Outcomes and the Path Forward.

Published in:

Journal of Endourology, 2024, v. 38, n. 11, p. e1241, doi. 10.1089/end.2024.0452

By:

Altobelli, Emanuela;
Kingma, Riemer;
Mors, Rianne;
Bus, Mieke T.J.;
de Jong, Igle J.;
Roemeling, Stijn

Publication type:

Article

Platinum exposure and cause-specific mortality among patients with testicular cancer.

Published in:

2019

By:

Groot, Harmke J;
van Leeuwen, Flora E;
Lubberts, Sjoukje;
Horenblas, Simon;
de Wit, Ronald;
Witjes, J Alfred;
Groenewegen, Gerard;
Poortmans, Philip M;
Hulshof, Maarten C C M;
Meijer, Otto W M;
de Jong, Igle J;
van den Berg, Hetty A;
Smilde, Tineke J;
Vanneste, Ben G L;
Aarts, Maureen J B;
Jóźwiak, Katarzyna;
van den Belt-Dusebout, Alexandra W;
Gietema, Jourik A;
Schaapveld, Michael

Publication type:

journal article

Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment.

Published in:

Cancer (0008543X), 2014, v. 120, n. 7, p. 968, doi. 10.1002/cncr.28518

By:

Badrising, Sushil;
van der Noort, Vincent;
van Oort, Inge M.;
van den Berg, H. Pieter;
Los, Maartje;
Hamberg, Paul;
Coenen, Jules L.;
van den Eertwegh, Alfons J. M.;
de Jong, Igle J.;
Kerver, Emile D.;
van Tinteren, Harm;
Bergman, Andries M.

Publication type:

Article

Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer.

Published in:

Oncology, 2016, v. 91, n. 5, p. 267, doi. 10.1159/000448219

By:

Badrising, Sushil K.;
van der Noort, Vincent;
Hamberg, Paul;
Coenen, Jules L.L.M.;
aarts, Maureen J.;
van Oort, Inge M.;
van den Eertwegh, alfons J.M.;
Los, Maartje;
van den Berg, H. Pieter;
Gelderblom, Hans;
Vrijaldenhoven, Suzan;
Kerver, Emile D.;
van Voorthuizen, Theo;
de Jong, Igle J.;
Haanen, John B.;
Bergman, andries M.

Publication type:

Article

18F-DCFPyL PET/CT in the Detection of Prostate Cancer at 60 and 120 Minutes: Detection Rate, Image Quality, Activity Kinetics, and Biodistribution.

Published in:

Journal of Nuclear Medicine, 2017, v. 58, n. 11, p. 1797, doi. 10.2967/jnumed.117.192658

By:

Wondergem, Maurits;
van der Zant, Friso M.;
Knol, Remco J. J.;
Lazarenko, Sergiy V.;
Pruim, Jan;
de Jong, Igle J.

Publication type:

Article

89Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma.

Published in:

Journal of Nuclear Medicine, 2017, v. 58, n. 6, p. 905, doi. 10.2967/jnumed.116.183475

By:

van Es, Suzanne C.;
Brouwers, Adrienne H.;
Mahesh, Shekar V. K.;
Leliveld-Kors, Annemarie M.;
de Jong, Igle J.;
Lub-de Hooge, Marjolijn N.;
de Vries, Elizabeth G. E.;
Gietema, Jourik A.;
Oosting, Sjoukje F.

Publication type:

Article

Molecular Imaging of Prostate Cancer: Tapping into the Opportunities.

Published in:

Journal of Nuclear Medicine, 2015, v. 56, n. 2, p. 169, doi. 10.2967/jnumed.114.150219

By:

Oyen, Wim J. G.;
De Jong, Igle J.

Publication type:

Article

89Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment.

Published in:

Journal of Nuclear Medicine, 2015, v. 56, n. 1, p. 63, doi. 10.2967/jnumed.114.144840

By:

Oosting, Sjoukje F.;
Brouwers, Adrienne H.;
van Es, Suzanne C.;
Nagengast, Wouter B.;
Munnink, Thijs H. Oude;
Lub-de Hooge, Marjolijn N.;
Hollema, Harry;
de Jong, Johan R.;
de Jong, Igle J.;
de Haas, Sanne;
Scherer, Stefan J.;
Sluiter, Wim J.;
Dierckx, Rudi A.;
Bongaerts, Alfons H. H.;
Gietema, Jourik A.;
de Vries, Elisabeth G. E.

Publication type:

Article

Preoperative Staging of Pelvic Lymph Nodes in Prostate Cancer by 11C-Choline PET.

Published in:

Journal of Nuclear Medicine, 2003, v. 44, n. 3, p. 331

By:

De Jong, Igle J.;
Pruim, Jan;
Elsinga, Philip H.;
Vaalburg, Willem;
Mensink, Han J.

Publication type:

Article

Prognostic Parameters for Response to Enzalutamide After Docetaxel and Abiraterone Treatment in Metastatic Castration-Resistant Prostate Cancer Patients; a Possible Time Relation.

Published in:

Prostate, 2016, v. 76, n. 1, p. 32, doi. 10.1002/pros.23094

By:

Badrising, Sushil K.;
van der Noort, Vincent;
van den Eertwegh, Alfons J.M.;
Hamberg, Paul;
van Oort, Inge M.;
van den Berg, Hendrik P.;
Los, Maartje;
Aarts, Maureen J.B.;
Coenen, Jules L.L.M.;
Gelderblom, Hans;
de Jong, Igle J.;
Kerver, Emile D.;
Vrijaldenhoven, Suzan;
van Voorthuizen, Theo;
Warmerdam, Fabienne;
Haanen, John B.;
Bergman, Andries M.

Publication type:

Article

EpCAM Expression in Lymph Node Metastases of Urothelial Cell Carcinoma of the Bladder: A Pilot Study.

Published in:

International Journal of Molecular Sciences, 2017, v. 18, n. 8, p. 1802, doi. 10.3390/ijms18081802

By:

van der Fels, Christa A. M.;
Rosati, Stefano;
de Jong, Igle J.

Publication type:

Article

EpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study.

Published in:

International Journal of Molecular Sciences, 2016, v. 17, n. 10, p. 1650, doi. 10.3390/ijms17101650

By:

Campos, Anna K.;
Hoving, Hilde D.;
Rosati, Stefano;
van Leenders, Geert J. L. H.;
de Jong, Igle J.

Publication type:

Article

PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy.

Published in:

International Journal of Molecular Sciences, 2014, v. 15, n. 4, p. 6046, doi. 10.3390/ijms15046046

By:

Rybalov, Maxim;
Ananias, Hildo J. K.;
Hoving, Hilde D.;
van der Poel, Henk G.;
Rosati, Stefano;
de Jong, Igle J.

Publication type:

Article

Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer.

Published in:

Prostate, 2009, v. 69, n. 10, p. 1101, doi. 10.1002/pros.20957

By:

Ananias, Hildo J.K.;
van den Heuvel, Marius C.;
Helfrich, Wijnand;
de Jong, Igle J.

Publication type:

Article

Predictive Value of Precision-Cut Kidney Slices as an Ex Vivo Screening Platform for Therapeutics in Human Renal Fibrosis.

Published in:

Pharmaceutics, 2020, v. 12, n. 5, p. 459, doi. 10.3390/pharmaceutics12050459

By:

Bigaeva, Emilia;
Puerta Cavanzo, Nataly;
Stribos, Elisabeth G. D.;
de Jong, Amos J.;
Biel, Carin;
Mutsaers, Henricus A. M.;
Jensen, Michael S.;
Nørregaard, Rikke;
Leliveld, Anna M.;
de Jong, Igle J.;
Hillebrands, Jan-Luuk;
van Goor, Harry;
Boersema, Miriam;
Bank, Ruud A.;
Olinga, Peter

Publication type:

Article

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β18F-fluoro-5α-dihydrotestosterone.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.253641

By:

Antunes, Inês F.;
Dost, Rutger J.;
Hoving, Hilde D.;
Waarde, Aren van;
O Dierckx, Rudi A. J.;
Samplonius, Douwe F.;
Helfrich, Wijnand;
Elsinga, Philip H.;
de Vries, Erik F. J.;
de Jong, Igle J.

Publication type:

Article

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β18F-fluoro-5α-dihydrotestosterone.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1

By:

Antunes, Inês F.;
Dost, Rutger J.;
Hoving, Hilde D.;
van Waarde, Aren;
Dierckx, Rudi A. J. O.;
Samplonius, Douwe F.;
Helfrich, W.;
Elsinga, Philip H.;
de Vries, Erik F. J.;
de Jong, Igle J.

Publication type:

Article

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.253641

By:

Antunes, Inês F.;
Dost, Rutger J.;
Hoving, Hilde D.;
van Waarde, Aren;
Dierckx, Rudi A. J. O.;
Samplonius, Douwe F.;
Helfrich, Wijnand;
Elsinga, Philip H.;
de Vries, Erik F. J.;
de Jong, Igle J.

Publication type:

Article

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β18F-fluoro-5α-dihydrotestosterone.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.253641

By:

Antunes, Inês F.;
Dost, Rutger J.;
Hoving, Hilde D.;
van Waarde, Aren;
Dierckx, Rudi A. J. O.;
Samplonius, Douwe F.;
Helfrich, Wijnand;
Elsinga, Philip H.;
de Vries, Erik F. J.;
de Jong, Igle J.

Publication type:

Article

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.253641

By:

Antunes, Inês F.;
Dost, Rutger J.;
Hoving, Hilde D.;
van Waarde, Aren;
Dierckx, Rudi A. J. O.;
Samplonius, Douwe F.;
Helfrich, Wijnand;
Elsinga, Philip H.;
de Vries, Erik F. J.;
de Jong, Igle J.

Publication type:

Article

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.253641

By:

Antunes, Inês F.;
Dost, Rutger J.;
Hoving, Hilde D.;
van Waarde, Aren;
Dierckx, Rudi A. J. O.;
Samplonius, Douwe F.;
Helfrich, Wijnand;
Elsinga, Philip H.;
de Vries, Erik F. J.;
de Jong, Igle J.

Publication type:

Article

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 29, doi. 10.2967/jnumed.120.253641

By:

Antunes, Inês F.;
Dost, Rutger J.;
Hoving, Hilde D.;
van Waarde, Aren;
Dierckx, Rudi A. J. O.;
Samplonius, Douwe F.;
Helfrich, Wijnand;
Elsinga, Philip H.;
de Vries, Erik F. J.;
de Jong, Igle J.

Publication type:

Article

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.253641

By:

Antunes, Inês F.;
Dost, Rutger J.;
Hoving, Hilde D.;
van Waarde, Aren;
Dierckx, Rudi A. J. O.;
Samplonius, Douwe F.;
Helfrich, Wijnand;
Elsinga, Philip H.;
de Vries, Erik F. J.;
de Jong, Igle J.

Publication type:

Article

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.253641

By:

Antunes, Inês F.;
Dost, Rutger J.;
Hoving, Hilde D.;
van Waarde, Aren;
Dierckx, Rudi A. J. O.;
Samplonius, Douwe F.;
Helfrich, Wijnand;
Elsinga, Philip H.;
de Vries, Erik F. J.;
de Jong, Igle J.

Publication type:

Article

In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2005, v. 32, n. 6, p. 668, doi. 10.1007/s00259-004-1741-4

By:

Breeuwsma, Anthonius J.;
Pruim, Jan;
Jongen, Maud M.;
Suurmeijer, Albert J.;
Vaalburg, Wim;
Nijman, Rien J.;
de Jong, Igle J.

Publication type:

Article

Visualisation of bladder cancer using [sup 11] C-choline PET: first clinical experience.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2002, v. 29, n. 10, p. 1283, doi. 10.1007/s00259-002-0881-7

By:

de Jong, Igle J.;
Pruim, Jan;
Elsinga, Philip H.;
Jongen, Maud J.;
Mensink, Han A.;
Vaalburg, Willem

Publication type:

Article

Compliance with biopsy recommendations of a prostate cancer risk calculator.

Published in:

BJU International, 2012, v. 109, n. 10, p. 1480, doi. 10.1111/j.1464-410X.2011.10611.x

By:

van Vugt, Heidi A.;
Roobol, Monique J.;
Busstra, Martijn;
Kil, Paul;
Oomens, Eric H.;
de Jong, Igle J.;
Bangma, Chris H.;
Steyerberg, Ewout W.;
Korfage, Ida

Publication type:

Article

Does Computed Tomography or Positron Emission Tomography/Computed Tomography Contribute to Detection of Small Focal Cancers in the Prostate?

Published in:

Journal of Endourology, 2010, v. 24, n. 5, p. 693, doi. 10.1089/end.2009.0470

By:

Li, Michael M.;
Rybalov, Maxim;
Haider, Masoom A.;
de Jong, Igle J.

Publication type:

Article

Works by de Jong, Igle J.

Optimization of Cone Beam Computed Tomography Scan Protocols for the Intraoperative Detection of Residual Stones in Percutaneous Nephrolithotomy.

Tc-HDP bone scintigraphy and F-sodiumfluoride PET/CT in primary staging of patients with prostate cancer.

Treatment and outcome in muscle invasive bladder cancer: a population-based survey.

Cognitive Impairment in Long-Term Survivors of Testicular Cancer More Than 20 Years after Treatment.

Response to: Fu-Xiang Lin, Yi Yu, Zhan-Ping Xu Letter to Editor: Unveiling the Crystal Clear: Cone Beam Computed Tomography's Role in Enhancing PCNL Outcomes and the Path Forward.

Platinum exposure and cause-specific mortality among patients with testicular cancer.

Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment.

Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer.

<sup>18</sup>F-DCFPyL PET/CT in the Detection of Prostate Cancer at 60 and 120 Minutes: Detection Rate, Image Quality, Activity Kinetics, and Biodistribution.

<sup>89</sup>Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma.

Molecular Imaging of Prostate Cancer: Tapping into the Opportunities.

<sup>89</sup>Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment.

Preoperative Staging of Pelvic Lymph Nodes in Prostate Cancer by <sup>11</sup>C-Choline PET.

Prognostic Parameters for Response to Enzalutamide After Docetaxel and Abiraterone Treatment in Metastatic Castration-Resistant Prostate Cancer Patients; a Possible Time Relation.

EpCAM Expression in Lymph Node Metastases of Urothelial Cell Carcinoma of the Bladder: A Pilot Study.

EpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study.

PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy.

Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer.

Predictive Value of Precision-Cut Kidney Slices as an Ex Vivo Screening Platform for Therapeutics in Human Renal Fibrosis.

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β18F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

In vivo uptake of [<sup>11</sup>C]choline does not correlate with cell proliferation in human prostate cancer.

Visualisation of bladder cancer using [sup 11] C-choline PET: first clinical experience.

Compliance with biopsy recommendations of a prostate cancer risk calculator.

Does Computed Tomography or Positron Emission Tomography/Computed Tomography Contribute to Detection of Small Focal Cancers in the Prostate?